The Forgotten Antiproteinuric Properties of Diuretics
- 7 July 2021
- journal article
- research article
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 52 (6) , 435-449
Abstract
Background: Although diuretics are one of the most widely used drugs by nephrologists, their antiproteinuric properties are not generally taken into consideration. Summary: Thiazide diuretics have been shown to reduce proteinuria by >35% in several prospective controlled studies, and these values are markedly increased when combined with a low-salt diet. Thiazide-like diuretics (indapamide and chlorthalidone) have shown similar effectiveness. The antiproteinuric effect of mineralocorticoid receptor antagonists (spironolactone, eplerenone, and finerenone) has been clearly established through prospective and controlled studies, and treatment with finerenone reduces the risk of chronic kidney disease progression in type-2 diabetic patients. The efficacy of other diuretics such as amiloride, triamterene, acetazolamide, or loop diuretics has been less explored, but different investigations suggest that they might share the same antiproteinuric properties of other diuretics that should be evaluated through controlled studies. Although the inclusion of sodium-glucose cotransporter-2 inhibitors (SGLT2i) among diuretics is a controversial issue, their renoprotective and cardioprotective properties, confirmed in various landmark trials, constitute a true revolution in the treatment of patients with kidney disease. Recent subanalyses of these trials have shown that the early antiproteinuric effect induced by SGLT2i predicts long-term preservation of kidney function. Key Message: Whether the early reduction in proteinuria induced by diuretics other than finerenone and SGLT2i, as summarized in this review, also translates into long-term renoprotection requires further prospective and observational studies. In any case, it is important for the clinician to be aware of the antiproteinuric properties of drugs so often used in daily clinical practice.Keywords
This publication has 118 references indexed in Scilit:
- Evolving importance of kidney disease: from subspecialty to global health burdenThe Lancet, 2013
- Moderate Antiproteinuric Effect of Add-On Aldosterone Blockade with Eplerenone in Non-Diabetic Chronic Kidney Disease. A Randomized Cross-Over StudyPLOS ONE, 2011
- Aldosterone Receptor AntagonistsCirculation, 2010
- Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesBMJ, 2009
- The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young menKidney International, 2007
- Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteinsAmerican Journal of Kidney Diseases, 1995
- Salt-Induced Increases in Systolic Blood Pressure Affect Renal Hemodynamics and ProteinuriaHypertension, 1995
- Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors.Hypertension, 1994
- Regression of microalbuminuria in type II diabetic, hypertensive patients after long-term indapamide treatmentAmerican Heart Journal, 1991
- Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuriaThe American Journal of Cardiology, 1990